HeartSciences Number of Employees 2022-2025 | HSCS

HeartSciences number of employees from 2022 to 2025. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
HeartSciences Annual Employee Count
2024 15
2023 12
2022 12
2021 13
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.004B $0.000B
Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.136B 58.95
Hims & Hers Health (HIMS) United States $12.000B 124.67
Tempus AI (TEM) United States $10.868B 0.00
IRhythm Technologies (IRTC) United States $4.592B 0.00
Inspire Medical Systems (INSP) United States $4.068B 63.55
Hinge Health (HNGE) United States $3.121B 0.00
Privia Health (PRVA) United States $2.805B 191.75
Enovis (ENOV) United States $1.818B 10.14
Schrodinger (SDGR) United States $1.741B 0.00
Clover Health Investments (CLOV) United States $1.567B 0.00
Phreesia (PHR) United States $1.501B 0.00
Omnicell (OMCL) United States $1.466B 25.86
Azenta (AZTA) United States $1.310B 60.89
10x Genomics (TXG) United States $1.150B 0.00
Fulgent Genetics (FLGT) United States $0.648B 0.00
Claritev (CTEV) United States $0.605B 0.00
Butterfly Network (BFLY) United States $0.591B 0.00
Talkspace (TALK) United States $0.553B 165.25
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.353B 784.00
Outset Medical (OM) United States $0.342B 0.00
Health Catalyst (HCAT) United States $0.275B 0.00
Nyxoah SA (NYXH) Belgium $0.263B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
KORU Medical Systems (KRMD) United States $0.130B 0.00
Pulmonx (LUNG) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.118B 0.00
American Well (AMWL) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.101B 0.00
CareCloud (CCLD) United States $0.091B 3.45
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
P3 Health Partners (PIII) United States $0.047B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00